• <th id="3yz4h"><track id="3yz4h"></track></th>

    1. <rp id="3yz4h"><object id="3yz4h"><input id="3yz4h"></input></object></rp>

      <em id="3yz4h"></em>
    2. 統一服務熱線:400-888-0207 在線咨詢 | 微信聯系
      首頁 > 產品 > 產品類型 > 試劑盒 > 免疫檢測
      SARS-CoV-2 sVNT/COVID-19 sVNT
      貨號:EL-1611-32214 | 規格:96 wells | 價格:¥13320.00 | 品牌:AffinityImmuno
      SARS-CoV-2 surrogate Virus Neutralizing Test (sVNT) (spike protein/ ACE2 ligand binding assay) COVID-19 sVNTSARS-CoV-2替代病毒中和測試(sVNT)(spike蛋白/ACE2配體結合檢測)COVID-19 sVNT 是由北京中昊新生科技有限公司提供,AffinityImmuno產品包括ELISA試劑盒和單克隆抗體,提供定制雞多克隆抗體的服務。AffinityImmuno Inc.針對COVID 19大流行推出了一系列試劑,其中包括各種多克隆抗體、病毒刺突蛋白ELISA試劑盒和病毒

      SARS-CoV-2替代病毒中和測試(sVNT)(spike蛋白/ACE2配體結合檢測)COVID-19 sVNT
      SARS-CoV-2 surrogate Virus Neutralizing Test (sVNT) (spike protein/ ACE2 ligand binding assay) COVID-19 sVNT


      AffinityImmuno Inc.’s SARS-CoV-2 spike protein-ligand binding assay (surrogate Virus Neutralization Test) allows rapid quantification of COVID-19 neutralizing antibodies in serum and plasma by measuring the reduction in binding of viral spike protein with its receptor ACE2. This assay allows rapid analysis of convalescent plasma, antibody-based therapeutics, vaccine leads, and immune response to the virus to measure the percent reduction in spike protein binding to ACE2. This serological platform was designed as a tool to understand the correlation between neutralizing antibody level and protective immunity in recovered SARS-CoV-2.


      This product helps to identify the presence of SARS-CoV-2 / COVID-19 neutralizing antibodies via surrogate virus neutralization testing (SVNT). This process is able to be conducted quickly in comparison to other detection methods such as Plaque Reduction Neutralization Test (PRNT) or similar cell culture based tests that take multiple days to perform. The AffinityImmuno sVNT test has a number of applications including convalescent plasma screening, vaccine response testing, small molecule ligand screening, and monitoring population immunity that could help to combat the global SARS-CoV-2 / COVID-19 pandemic.

      sVNT-serum-data-800x736.jpeg

      Comparison of 62 serum samples from recovered, COVID-19 individuals to 260 non-COVID-19 (self-declared) individuals demonstrates the presence of virus neutralizing antibodies that prevent binding between the spike protein and its receptor, ACE2.

      相關產品
      相關資料
      欧美熟女性生活
    3. <th id="3yz4h"><track id="3yz4h"></track></th>

      1. <rp id="3yz4h"><object id="3yz4h"><input id="3yz4h"></input></object></rp>

        <em id="3yz4h"></em>